What is Healthcare Tr Amer Inc's earnings per share (EPS)?

Healthcare Tr Amer Inc (HR) reported diluted earnings per share of $-0.71 for fiscal year 2025. This represents a 60.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Healthcare Tr Amer Inc Financials

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Healthcare Tr Amer Inc (HR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HR FY2025 2026-05-01

Cash-generating real estate is being shrunk and deleveraged, with asset monetization doing more balance-sheet work than earnings.

From FY2023 to FY2025, operating cash flow stayed near $500M even while net income remained negative and revenue slipped, because heavy depreciation of $564M in FY2025 kept accounting losses much worse than cash generation. At the same time, positive investing cash flow alongside lower long-term debt shows the company has been recycling assets into cash and using that cash to reduce borrowings rather than to expand.

The balance sheet is moving toward a lighter, less leveraged posture: total assets fell from $12.6B in FY2023 to $9.2B in FY2025 while debt also fell, so balance-sheet repair has come with a smaller asset base.

Dividend coverage is tight rather than abundant: FY2025 operating cash flow of $457.1M only modestly exceeded dividends paid of $386.9M, which helps explain the lower payout. Because financing cash flow stayed negative, the leftover cash has mainly supported debt reduction instead of new portfolio growth.

Financial Health Signals

Financial Health Score 18/100

Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Healthcare Tr Amer Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin

FFO Growth

AFFO Margin

Dividend Cov.

Piotroski F-Score Partial

6/7

Healthcare Tr Amer Inc passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-1.83x

For every $1 of reported earnings, Healthcare Tr Amer Inc generates $-1.83 in operating cash flow ($457.1M OCF vs -$249.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.2B

YoY-6.9%

5Y CAGR+18.8%

10Y CAGR+11.3%

Healthcare Tr Amer Inc generated $1.2B in revenue in fiscal year 2025. This represents a decrease of 6.9% from the prior year.

EBITDA

N/A

Net Income

-$249.5M

YoY+62.4%

Healthcare Tr Amer Inc reported -$249.5M in net income in fiscal year 2025. This represents an increase of 62.4% from the prior year.

EPS (Diluted)

$-0.71

YoY+60.8%

Healthcare Tr Amer Inc earned $-0.71 per diluted share (EPS) in fiscal year 2025. This represents an increase of 60.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$26.2M

YoY-62.0%

5Y CAGR-25.7%

10Y CAGR+7.2%

Healthcare Tr Amer Inc held $26.2M in cash against $3.9B in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.10

YoY-11.3%

5Y CAGR-1.7%

10Y CAGR-0.6%

Healthcare Tr Amer Inc paid $1.10 per share in dividends in fiscal year 2025. This represents a decrease of 11.3% from the prior year.

Shares Outstanding

349M

YoY-0.6%

5Y CAGR+9.8%

Healthcare Tr Amer Inc had 349M shares outstanding in fiscal year 2025. This represents a decrease of 0.6% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

-21.1%

YoY+31.2pp

5Y CAGR-35.6pp

10Y CAGR-29.3pp

Healthcare Tr Amer Inc's net profit margin was -21.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 31.2 percentage points from the prior year.

Return on Equity

-5.4%

YoY+7.3pp

5Y CAGR-9.1pp

10Y CAGR-7.8pp

Healthcare Tr Amer Inc's ROE was -5.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 7.3 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$4.0M

YoY-54.9%

5Y CAGR+22.8%

10Y CAGR+9.2%

Healthcare Tr Amer Inc spent $4.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 54.9% from the prior year.

Capital Expenditures

N/A

HR Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.2B-6.9%	$1.3B-5.6%	$1.3B+44.1%	$932.6M+74.4%	$534.8M+7.0%	$499.6M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$72.6M-12.7%	$83.1M+42.3%	$58.4M+10.8%	$52.7M+54.4%	$34.2M+11.2%	$30.7M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$209.0M-13.8%	$242.4M-6.2%	$258.6M+76.3%	$146.7M+176.1%	$53.1M-5.4%	$56.2M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$249.5M+62.4%	-$663.9M-135.4%	-$282.1M-793.2%	$40.7M-39.0%	$66.7M-7.7%	$72.2M
EPS (Diluted)	$-0.71+60.8%	$-1.81-144.6%	$-0.74-593.3%	$0.15-66.7%	$0.45-13.5%	$0.52

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$279.0M-2.6%	$286.3M-3.8%	$297.8M+0.1%	$297.5M-0.5%	$299.0M-3.5%	$309.8M-1.8%	$315.4M-0.3%	$316.3M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$17.3M+25.8%	$13.8M-36.7%	$21.8M-7.3%	$23.5M+73.6%	$13.5M-60.4%	$34.2M+70.0%	$20.1M+43.7%	$14.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$43.9M-8.9%	$48.2M-8.5%	$52.6M-1.3%	$53.3M-2.7%	$54.8M-5.9%	$58.3M-3.9%	$60.6M-2.9%	$62.5M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$56K-100.5%	$11.0M+119.0%	-$57.7M+63.4%	-$157.9M-251.8%	-$44.9M+61.4%	-$116.3M-25.0%	-$93.0M+35.3%	-$143.8M
EPS (Diluted)	$0.00	N/A	$-0.17+62.2%	$-0.45-246.2%	$-0.13	N/A	$-0.26+33.3%	$-0.39

HR Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$9.2B-13.5%	$10.7B-15.7%	$12.6B-8.8%	$13.8B+225.2%	$4.3B-37.3%	$6.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$26.2M-62.0%	$68.9M+168.2%	$25.7M-57.8%	$61.0M+362.7%	$13.2M-88.6%	$115.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$32.8M-10.1%	$36.5M-42.3%	$63.2M+15.6%	$54.7M+288.5%	$14.1M-20.6%	$17.7M
Goodwill	N/A	$0-100.0%	$250.5M+12.2%	$223.2M+6301.0%	$3.5M	N/A
Total Liabilities	$4.5B-15.2%	$5.3B-6.5%	$5.7B-7.4%	$6.2B+197.4%	$2.1B-41.7%	$3.6B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$3.9B-16.1%	$4.7B-6.6%	$5.0B-6.7%	$5.4B+197.1%	$1.8B-40.5%	$3.0B
Total Equity	$4.6B-11.8%	$5.2B-23.3%	$6.8B-9.9%	$7.6B+246.5%	$2.2B+12.2%	$1.9B
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$9.1B-0.7%	$9.2B-6.6%	$9.9B-3.7%	$10.2B-2.5%	$10.5B-1.5%	$10.7B-5.3%	$11.2B-4.7%	$11.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$26.2M+0.2%	$26.2M-39.6%	$43.3M+69.9%	$25.5M-0.8%	$25.7M-62.7%	$68.9M+202.2%	$22.8M-45.4%	$41.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	$32.8M	N/A	N/A	N/A	$36.5M	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	$0	$0	$0
Total Liabilities	$4.7B+2.6%	$4.5B-11.4%	$5.1B-4.5%	$5.4B+0.1%	$5.3B+0.1%	$5.3B-5.3%	$5.6B-3.2%	$5.8B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$4.1B+4.9%	$3.9B-12.8%	$4.5B-4.4%	$4.7B-0.8%	$4.7B+1.5%	$4.7B-6.0%	$5.0B-3.7%	$5.1B
Total Equity	$4.4B-3.8%	$4.6B-1.4%	$4.7B-2.8%	$4.8B-5.1%	$5.1B-3.0%	$5.2B-5.1%	$5.5B-6.3%	$5.9B
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

HR Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$457.1M-8.9%	$501.6M+0.4%	$499.8M+83.3%	$272.7M+17.2%	$232.6M-50.5%	$470.1M
Capital Expenditures	N/A	N/A	N/A	N/A	$97.2M+30.0%	$74.7M
Free Cash Flow	N/A	N/A	N/A	N/A	$135.5M-65.7%	$395.3M
Investing Cash Flow	$710.8M-21.1%	$900.9M+158.0%	$349.1M-78.6%	$1.6B+390.6%	-$562.5M-1.3%	-$555.2M
Financing Cash Flow	-$1.2B+10.9%	-$1.4B-53.7%	-$884.2M+52.4%	-$1.9B-667.4%	$327.7M+228.6%	$99.7M
Dividends Paid	$386.9M-15.5%	$457.9M-3.0%	$472.2M+66.5%	$283.7M+61.7%	$175.5M+7.9%	$162.6M
Share Buybacks	$4.0M-54.9%	$8.9M+286.5%	$2.3M-28.0%	$3.2M-16.1%	$3.8M+164.8%	$1.4M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$52.9M-60.0%	$132.3M+16.3%	$113.8M-30.3%	$163.2M+241.5%	$47.8M-65.4%	$138.0M+15.7%	$119.3M-29.1%	$168.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$45.3M-108.6%	$526.5M+132.7%	$226.3M+7403.9%	-$3.1M+92.0%	-$38.8M-109.3%	$418.8M+26.6%	$330.8M+57.5%	$209.9M
Financing Cash Flow	-$7.5M+98.9%	-$676.1M-109.9%	-$322.2M-101.1%	-$160.2M-207.2%	-$52.1M+89.9%	-$514.0M-10.4%	-$465.7M-28.5%	-$362.5M
Dividends Paid	$83.9M-0.6%	$84.4M-0.4%	$84.8M-22.2%	$108.9M+0.1%	$108.8M-0.9%	$109.8M-2.4%	$112.4M-4.2%	$117.3M
Share Buybacks	$2.0M+438.5%	$379K-87.0%	$2.9M+485.3%	$498K+131.6%	$215K-97.5%	$8.6M	$0-100.0%	$3K

HR Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-21.1%+31.2pp	-52.3%-31.4pp	-21.0%-25.4pp	4.4%-8.1pp	12.5%-2.0pp	14.4%
Return on Equity	-5.4%+7.3pp	-12.7%-8.5pp	-4.1%-4.7pp	0.5%-2.5pp	3.0%-0.7pp	3.7%
Return on Assets	-2.7%+3.5pp	-6.2%-4.0pp	-2.2%-2.5pp	0.3%-1.3pp	1.6%+0.5pp	1.1%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.85-0.0	0.89+0.2	0.73+0.0	0.71-0.1	0.82-0.7	1.55
FCF Margin	N/A	N/A	N/A	N/A	25.3%-53.8pp	79.1%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-0.0%-3.9pp	3.8%+23.2pp	-19.4%+33.7pp	-53.1%-38.0pp	-15.0%+22.5pp	-37.5%-8.0pp	-29.5%+16.0pp	-45.5%
Return on Equity	0.0%-0.2pp	0.2%+1.5pp	-1.2%+2.1pp	-3.3%-2.4pp	-0.9%+1.3pp	-2.2%-0.5pp	-1.7%+0.8pp	-2.4%
Return on Assets	0.0%-0.1pp	0.1%+0.7pp	-0.6%+1.0pp	-1.5%-1.1pp	-0.4%+0.7pp	-1.1%-0.3pp	-0.8%+0.4pp	-1.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.92+0.1	0.85-0.1	0.96-0.0	0.97+0.0	0.93+0.0	0.890.0	0.90+0.0	0.87
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

AMERICAN HEALTHCARE REIT INC AHR

$11.1B

Caretrust CTRE

$10.2B

Sabra Health Care Reit Inc SBRA

$5.6B

National Health Investors NHI

$3.9B

Medical Prop MPW

$3.0B

Frequently Asked Questions

What is Healthcare Tr Amer Inc's annual revenue?

Healthcare Tr Amer Inc (HR) reported $1.2B in total revenue for fiscal year 2025. This represents a -6.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthcare Tr Amer Inc's revenue growing?

Healthcare Tr Amer Inc (HR) revenue declined by 6.9% year-over-year, from $1.3B to $1.2B in fiscal year 2025.

Is Healthcare Tr Amer Inc profitable?

No, Healthcare Tr Amer Inc (HR) reported a net income of -$249.5M in fiscal year 2025, with a net profit margin of -21.1%.

How much debt does Healthcare Tr Amer Inc have?

As of fiscal year 2025, Healthcare Tr Amer Inc (HR) had $26.2M in cash and equivalents against $3.9B in long-term debt.

What is Healthcare Tr Amer Inc's net profit margin?

Healthcare Tr Amer Inc (HR) had a net profit margin of -21.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Healthcare Tr Amer Inc pay dividends?

Yes, Healthcare Tr Amer Inc (HR) paid $1.10 per share in dividends during fiscal year 2025.

What is Healthcare Tr Amer Inc's return on equity (ROE)?

Healthcare Tr Amer Inc (HR) has a return on equity of -5.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthcare Tr Amer Inc's operating cash flow?

Healthcare Tr Amer Inc (HR) generated $457.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Healthcare Tr Amer Inc's total assets?

Healthcare Tr Amer Inc (HR) had $9.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Healthcare Tr Amer Inc buy back shares?

Yes, Healthcare Tr Amer Inc (HR) spent $4.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Healthcare Tr Amer Inc have outstanding?

Healthcare Tr Amer Inc (HR) had 349M shares outstanding as of fiscal year 2025.

What is Healthcare Tr Amer Inc's debt-to-equity ratio?

Healthcare Tr Amer Inc (HR) had a debt-to-equity ratio of 0.85 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthcare Tr Amer Inc's return on assets (ROA)?

Healthcare Tr Amer Inc (HR) had a return on assets of -2.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthcare Tr Amer Inc's Piotroski F-Score?

Healthcare Tr Amer Inc (HR) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthcare Tr Amer Inc's earnings high quality?

Healthcare Tr Amer Inc (HR) has an earnings quality ratio of -1.83x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Healthcare Tr Amer Inc?

Healthcare Tr Amer Inc (HR) scores 18 out of 100 on our Financial Health Score, indicating weak standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.